Ho-Am Prize in Science

Charles Lee of The Jackson Laboratory inducted as a fellow of The Korean Academy of Science and Technology

Retrieved on: 
Thursday, December 14, 2023
Genetic distance, AAAS, Genetics, Research, Jackson Laboratory, FACMG, Disease, KAST, Genomics, Ho-Am Prize in Science, HUGO, JAX, Faculty, Human Genome Organisation, Health, DSM-IV codes, Genome, Harvard Medical School, Natural science, Brigham and Women's Hospital, Biology, AACR, Hospital, Lee, Pharmaceutical industry, Medicine

FARMINGTON, Conn., Dec. 14, 2023 /PRNewswire/ -- The Korean Academy of Science and Technology (KAST), the highest institution of its kind in South Korea, announced Charles Lee, Ph.D., FACMG , as a newly inducted fellow of the Academy.

Key Points: 
  • FARMINGTON, Conn., Dec. 14, 2023 /PRNewswire/ -- The Korean Academy of Science and Technology (KAST), the highest institution of its kind in South Korea, announced Charles Lee, Ph.D., FACMG , as a newly inducted fellow of the Academy.
  • Lee is the scientific director and professor at The Jackson Laboratory for Genomic Medicine, and is the Robert Alvine Family Endowed Chair.
  • "I am profoundly honored to join so many inspirational scientists and colleagues who are members of the Korean Academy of Science and Technology, and am deeply grateful for this tremendous opportunity," says Lee.
  • Dr. Lee is also responsible for the scientific direction and coordination of The Jackson Laboratory (JAX) for Genomic Medicine.

Dr. Sangtae Kim to Lead Verseon's New AI and Data-Science Initiative as CTO

Retrieved on: 
Wednesday, January 12, 2022
Biological engineering, Chemical engineering, Research, CTO, BS, NSF, American Institute of Chemical Engineers, Science, Collection, Ho-Am Prize in Engineering, Morgridge Institute for Research, CEO, American Institute for Medical and Biological Engineering, Drug design, Hereditary angioedema, Government, Eli Lilly, Lists of diseases, Distinguishing, Initiative, Warner–Lambert, Ho-Am Prize in Science, National Academy of Engineering, University of Wisconsin–Madison, American Institute, William O. Baker Award for Initiatives in Research, Drug development, Doctor of Philosophy, National, AI, Verseon, Medicine, National academy, Sang, University, Diabetic retinopathy, Microfluidics, Pharmaceutical industry, Management, Engineering, Purdue University, California Institute of Technology

FREMONT, Calif., Jan. 12, 2022 /PRNewswire/ -- Verseon is pleased to announce the appointment of its new CTO, Dr. Sangtae (Sang) Kim.

Key Points: 
  • FREMONT, Calif., Jan. 12, 2022 /PRNewswire/ -- Verseon is pleased to announce the appointment of its new CTO, Dr. Sangtae (Sang) Kim.
  • Sang, a member of the US National Academy of Engineering , will spearhead expansion of the company's data-science and AI initiatives.
  • Sang's engineering and data-science expertise will both complement and expand Verseon's already significant technological advantages in computer-driven drug design.
  • In recent years he has started research initiatives to use AI for multiple aspects of drug design and development.